1
|
Liang R, Shen X, Wang F, Wang X, DesJarlais A, Syed A, Saba R, Tan Z, Yu F, Ji X, Shrestha S, Ren Y, Yang J, Park Y, Schwartz RJ, Soibam B, McConnell BK, Stewart MD, Kumar A, Liu Y. H19X-encoded miR-322(424)/miR-503 regulates muscle mass by targeting translation initiation factors. J Cachexia Sarcopenia Muscle 2021; 12:2174-2186. [PMID: 34704401 PMCID: PMC8718088 DOI: 10.1002/jcsm.12827] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 09/02/2021] [Accepted: 09/11/2021] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Skeletal muscle atrophy is a debilitating complication of many chronic diseases, disuse conditions, and ageing. Genome-wide gene expression analyses have identified that elevated levels of microRNAs encoded by the H19X locus are among the most significant changes in skeletal muscles in a wide scope of human cachectic conditions. We have previously reported that the H19X locus is important for the establishment of striated muscle fate during embryogenesis. However, the role of H19X-encoded microRNAs in regulating skeletal mass in adults is unknown. METHODS We have created a transgenic mouse strain in which ectopic expression of miR-322/miR-503 is driven by the skeletal muscle-specific muscle creatine kinase promoter. We also used an H19X mutant mouse strain in which transcription from the locus is interrupted by a gene trap. Animal phenotypes were analysed by standard histological methods. Underlying mechanisms were explored by using transcriptome profiling and validated in the two animal models and cultured myotubes. RESULTS Our results demonstrate that the levels of H19X microRNAs are inversely related to postnatal skeletal muscle growth. Targeted overexpression of miR-322/miR-503 impeded skeletal muscle growth. The weight of gastrocnemius muscles of transgenic mice was only 54.5% of the counterparts of wild-type littermates. By contrast, interruption of transcription from the H19X locus stimulates postnatal muscle growth by 14.4-14.9% and attenuates the loss of skeletal muscle mass in response to starvation by 12.8-21.0%. Impeded muscle growth was not caused by impaired IGF1/AKT/mTOR signalling or a hyperactive ubiquitin-proteasome system, instead accompanied by markedly dropped abundance of translation initiation factors in transgenic mice. miR-322/miR-503 directly targets eIF4E, eIF4G1, eIF4B, eIF2B5, and eIF3M. CONCLUSIONS Our study illustrates a novel pathway wherein H19X microRNAs regulate skeletal muscle growth and atrophy through regulating the abundance of translation initiation factors, thereby protein synthesis. The study highlights how translation initiation factors lie at the crux of multiple signalling pathways that control skeletal muscle mass.
Collapse
Affiliation(s)
- Rui Liang
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Xiaopeng Shen
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Fan Wang
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.,Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China
| | - Xin Wang
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.,Department of Oncology, Shangluo Central Hospital, Shangluo, Shaanxi Province, China
| | - Alex DesJarlais
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Anam Syed
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Raymond Saba
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Zhi Tan
- Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Fang Yu
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.,Department of Oncology, Shangluo Central Hospital, Shangluo, Shaanxi Province, China
| | - Xuan Ji
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Shreesti Shrestha
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Yinghong Ren
- Department of Oncology, Shangluo Central Hospital, Shangluo, Shaanxi Province, China
| | - Jin Yang
- Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China
| | - Yoonjung Park
- Department of Health and Human Performance, University of Houston, Houston, TX, USA
| | - Robert J Schwartz
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Benjamin Soibam
- Department of Computer Science and Engineering Technology, University of Houston-Downtown, Houston, TX, USA
| | - Bradley K McConnell
- Department of Pharmacological & Pharmaceutical Sciences, University of Houston, Houston, TX, USA
| | - M David Stewart
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| | - Ashok Kumar
- Department of Pharmacological & Pharmaceutical Sciences, University of Houston, Houston, TX, USA
| | - Yu Liu
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA
| |
Collapse
|